| Interactions between Microbiome and DME (MICBIO)
|
| Bacteria: Actinobacteria |
| Bifidobacterium adolescentis (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 4 Drugs Metabolized
|
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bifidobacterium adolescentis co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bifidobacterium adolescentis co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bifidobacterium adolescentis co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bifidobacterium adolescentis co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Bifidobacterium breve (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 6 Drugs Metabolized
|
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bifidobacterium breve co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bifidobacterium breve co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bifidobacterium breve co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bifidobacterium breve co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Ranitidine |
Click to Show/Hide the Detail |
| Drug ID |
DR1393
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bifidobacterium breve co-metabolize the drug Ranitidine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[6], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bifidobacterium breve co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Bifidobacterium longum (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 4 Drugs Metabolized
|
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bifidobacterium longum co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bifidobacterium longum co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [8] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bifidobacterium longum co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bifidobacterium longum co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Bifidobacterium ruminatum (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 4 Drugs Metabolized
|
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bifidobacterium ruminatum co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bifidobacterium ruminatum co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bifidobacterium ruminatum co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Ramelteon |
Click to Show/Hide the Detail |
| Drug ID |
DR1391
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bifidobacterium ruminatum co-metabolize the drug Ramelteon, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Collinsella aerofaciens (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Zidovudine |
Click to Show/Hide the Detail |
| Drug ID |
DR1729
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Collinsella aerofaciens co-metabolize the drug Zidovudine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
| Collinsella intestinalis (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Collinsella intestinalis co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Collinsella intestinalis co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Collinsella intestinalis co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Eggerthella lenta (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 4 Drugs Metabolized
|
| Dopamine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0532
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Eggerthella lenta co-metabolize the drug Dopamine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[11], [12] |
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Eggerthella lenta co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Eggerthella lenta co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Eggerthella lenta co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Mycobacterium tuberculosis (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Dextromethorphan hydrobromide |
Click to Show/Hide the Detail |
| Drug ID |
DR0476
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Mycobacterium tuberculosis co-metabolize the drug Dextromethorphan hydrobromide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[13], [14] |
| Nocardia farcinica (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Rifampicin |
Click to Show/Hide the Detail |
| Drug ID |
DR1420
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Nocardia farcinica co-metabolize the drug Rifampicin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[15], [16] |
| Streptomyces avermitilis (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Diclofenac sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR0488
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Streptomyces avermitilis co-metabolize the drug Diclofenac sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[17], [18], [19] |
| Testosterone cypionate |
Click to Show/Hide the Detail |
| Drug ID |
DR1564
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Streptomyces avermitilis co-metabolize the drug Testosterone cypionate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[20], [21], [18] |
| Bacteria: Bacteroidetes |
| Alistipes indistinctus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 7 Drugs Metabolized
|
| Cyclophosphamide |
Click to Show/Hide the Detail |
| Drug ID |
DR0391
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Alistipes indistinctus co-metabolize the drug Cyclophosphamide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[22], [2] |
| Diltiazem hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0509
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Alistipes indistinctus co-metabolize the drug Diltiazem hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[23], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Alistipes indistinctus co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Alistipes indistinctus co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Alistipes indistinctus co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Alistipes indistinctus co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Vilazodone hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1687
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Alistipes indistinctus co-metabolize the drug Vilazodone hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[24], [2] |
| Alloprevotella tannerae (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Amoxicillin |
Click to Show/Hide the Detail |
| Drug ID |
DR0104
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Alloprevotella tannerae co-metabolize the drug Amoxicillin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [26] |
| Bacteroides caccae (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Amoxicillin |
Click to Show/Hide the Detail |
| Drug ID |
DR0104
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides caccae co-metabolize the drug Amoxicillin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [27] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides caccae co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides caccae co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Bacteroides cellulosilyticus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 8 Drugs Metabolized
|
| Amoxicillin |
Click to Show/Hide the Detail |
| Drug ID |
DR0104
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides cellulosilyticus co-metabolize the drug Amoxicillin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [27] |
| Carisoprodol |
Click to Show/Hide the Detail |
| Drug ID |
DR0277
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides cellulosilyticus co-metabolize the drug Carisoprodol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[28], [2] |
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides cellulosilyticus co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides cellulosilyticus co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides cellulosilyticus co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides cellulosilyticus co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides cellulosilyticus co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Vilazodone hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1687
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides cellulosilyticus co-metabolize the drug Vilazodone hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[24], [2] |
| Bacteroides coprophilus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 8 Drugs Metabolized
|
| Carisoprodol |
Click to Show/Hide the Detail |
| Drug ID |
DR0277
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides coprophilus co-metabolize the drug Carisoprodol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[28], [2] |
| Clopidogrel bisulfate |
Click to Show/Hide the Detail |
| Drug ID |
DR0355
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides coprophilus co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[29], [2] |
| Glipizide |
Click to Show/Hide the Detail |
| Drug ID |
DR0778
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides coprophilus co-metabolize the drug Glipizide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[30], [2] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides coprophilus co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides coprophilus co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides coprophilus co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides coprophilus co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Vilazodone hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1687
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides coprophilus co-metabolize the drug Vilazodone hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[24], [2] |
| Bacteroides dorei (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 20 Drugs Metabolized
|
| Amoxicillin |
Click to Show/Hide the Detail |
| Drug ID |
DR0104
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides dorei co-metabolize the drug Amoxicillin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [27] |
| Carisoprodol |
Click to Show/Hide the Detail |
| Drug ID |
DR0277
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides dorei co-metabolize the drug Carisoprodol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[28], [2] |
| Clopidogrel bisulfate |
Click to Show/Hide the Detail |
| Drug ID |
DR0355
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides dorei co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[29], [2] |
| Diclofenac sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR0488
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) metabolizes the drug Diclofenac sodium, and Bacteroides dorei further metabolizes its metabolite (Diclofenac glucuronide), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[17], [31] |
| Diltiazem hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0509
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides dorei co-metabolize the drug Diltiazem hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[23], [2] |
| Doxazosin |
Click to Show/Hide the Detail |
| Drug ID |
DR0542
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides dorei co-metabolize the drug Doxazosin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[32], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides dorei co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Gliclazide |
Click to Show/Hide the Detail |
| Drug ID |
DR0776
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides dorei co-metabolize the drug Gliclazide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[33], [2] |
| Glipizide |
Click to Show/Hide the Detail |
| Drug ID |
DR0778
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides dorei co-metabolize the drug Glipizide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[30], [2] |
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides dorei co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Methsuximide |
Click to Show/Hide the Detail |
| Drug ID |
DR1050
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides dorei co-metabolize the drug Methsuximide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[34], [2] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides dorei co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides dorei co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides dorei co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Phenytoin |
Click to Show/Hide the Detail |
| Drug ID |
DR1282
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides dorei co-metabolize the drug Phenytoin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
| Ramelteon |
Click to Show/Hide the Detail |
| Drug ID |
DR1391
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides dorei co-metabolize the drug Ramelteon, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides dorei co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Venlafaxine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1679
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides dorei co-metabolize the drug Venlafaxine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[35], [2] |
| Vilazodone hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1687
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides dorei co-metabolize the drug Vilazodone hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[24], [2] |
| Voriconazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1709
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides dorei co-metabolize the drug Voriconazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[36], [2] |
| Bacteroides eggerthii (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 8 Drugs Metabolized
|
| Amoxicillin |
Click to Show/Hide the Detail |
| Drug ID |
DR0104
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides eggerthii co-metabolize the drug Amoxicillin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [37] |
| Clopidogrel bisulfate |
Click to Show/Hide the Detail |
| Drug ID |
DR0355
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides eggerthii co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[29], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides eggerthii co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides eggerthii co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides eggerthii co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides eggerthii co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Ramelteon |
Click to Show/Hide the Detail |
| Drug ID |
DR1391
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides eggerthii co-metabolize the drug Ramelteon, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Vilazodone hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1687
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides eggerthii co-metabolize the drug Vilazodone hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[24], [2] |
| Bacteroides finegoldii (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides finegoldii co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides finegoldii co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides finegoldii co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Bacteroides fragilis (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 19 Drugs Metabolized
|
| Amoxicillin |
Click to Show/Hide the Detail |
| Drug ID |
DR0104
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides fragilis co-metabolize the drug Amoxicillin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [27] |
| Carisoprodol |
Click to Show/Hide the Detail |
| Drug ID |
DR0277
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides fragilis co-metabolize the drug Carisoprodol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[28], [2] |
| Clopidogrel bisulfate |
Click to Show/Hide the Detail |
| Drug ID |
DR0355
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides fragilis co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[29], [2] |
| Cyclophosphamide |
Click to Show/Hide the Detail |
| Drug ID |
DR0391
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides fragilis co-metabolize the drug Cyclophosphamide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[22], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides fragilis co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Gliclazide |
Click to Show/Hide the Detail |
| Drug ID |
DR0776
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides fragilis co-metabolize the drug Gliclazide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[33], [2] |
| Glipizide |
Click to Show/Hide the Detail |
| Drug ID |
DR0778
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides fragilis co-metabolize the drug Glipizide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[30], [2] |
| Indomethacin |
Click to Show/Hide the Detail |
| Drug ID |
DR0875
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides fragilis co-metabolize the drug Indomethacin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Lofexidine |
Click to Show/Hide the Detail |
| Drug ID |
DR0967
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides fragilis co-metabolize the drug Lofexidine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[38], [2] |
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides fragilis co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Naftopidil |
Click to Show/Hide the Detail |
| Drug ID |
DR1124
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides fragilis co-metabolize the drug Naftopidil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[39], [2] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides fragilis co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides fragilis co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides fragilis co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Ramelteon |
Click to Show/Hide the Detail |
| Drug ID |
DR1391
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides fragilis co-metabolize the drug Ramelteon, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Ranitidine |
Click to Show/Hide the Detail |
| Drug ID |
DR1393
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides fragilis co-metabolize the drug Ranitidine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[6], [2] |
| Vilazodone hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1687
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides fragilis co-metabolize the drug Vilazodone hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[24], [2] |
| Voriconazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1709
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides fragilis co-metabolize the drug Voriconazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[36], [2] |
| Warfarin sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1717
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides fragilis co-metabolize the drug Warfarin sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[40], [2] |
| Bacteroides intestinalis (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 8 Drugs Metabolized
|
| Amoxicillin |
Click to Show/Hide the Detail |
| Drug ID |
DR0104
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides intestinalis co-metabolize the drug Amoxicillin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [27] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides intestinalis co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides intestinalis co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides intestinalis co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides intestinalis co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides intestinalis co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides intestinalis co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Vilazodone hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1687
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides intestinalis co-metabolize the drug Vilazodone hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[24], [2] |
| Bacteroides oleiciplenus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides oleiciplenus co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [41] |
| Bacteroides ovatus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 8 Drugs Metabolized
|
| Amoxicillin |
Click to Show/Hide the Detail |
| Drug ID |
DR0104
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides ovatus co-metabolize the drug Amoxicillin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [27] |
| Clopidogrel bisulfate |
Click to Show/Hide the Detail |
| Drug ID |
DR0355
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides ovatus co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[29], [2] |
| Diltiazem hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0509
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides ovatus co-metabolize the drug Diltiazem hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[23], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides ovatus co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides ovatus co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides ovatus co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides ovatus co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Vilazodone hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1687
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides ovatus co-metabolize the drug Vilazodone hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[24], [2] |
| Bacteroides sartorii (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 14 Drugs Metabolized
|
| Carisoprodol |
Click to Show/Hide the Detail |
| Drug ID |
DR0277
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides sartorii co-metabolize the drug Carisoprodol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[28], [2] |
| Clopidogrel bisulfate |
Click to Show/Hide the Detail |
| Drug ID |
DR0355
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides sartorii co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[29], [2] |
| Diltiazem hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0509
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides sartorii co-metabolize the drug Diltiazem hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[23], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides sartorii co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Indomethacin |
Click to Show/Hide the Detail |
| Drug ID |
DR0875
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides sartorii co-metabolize the drug Indomethacin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides sartorii co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides sartorii co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides sartorii co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides sartorii co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Phenytoin |
Click to Show/Hide the Detail |
| Drug ID |
DR1282
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides sartorii co-metabolize the drug Phenytoin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
| Ramelteon |
Click to Show/Hide the Detail |
| Drug ID |
DR1391
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides sartorii co-metabolize the drug Ramelteon, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Venlafaxine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1679
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides sartorii co-metabolize the drug Venlafaxine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[35], [2] |
| Vilazodone hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1687
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides sartorii co-metabolize the drug Vilazodone hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[24], [2] |
| Voriconazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1709
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides sartorii co-metabolize the drug Voriconazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[36], [2] |
| Bacteroides stercoris (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 11 Drugs Metabolized
|
| Amoxicillin |
Click to Show/Hide the Detail |
| Drug ID |
DR0104
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides stercoris co-metabolize the drug Amoxicillin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [27] |
| Carisoprodol |
Click to Show/Hide the Detail |
| Drug ID |
DR0277
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides stercoris co-metabolize the drug Carisoprodol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[28], [2] |
| Clopidogrel bisulfate |
Click to Show/Hide the Detail |
| Drug ID |
DR0355
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides stercoris co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[29], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides stercoris co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Indomethacin |
Click to Show/Hide the Detail |
| Drug ID |
DR0875
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides stercoris co-metabolize the drug Indomethacin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides stercoris co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides stercoris co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides stercoris co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Ramelteon |
Click to Show/Hide the Detail |
| Drug ID |
DR1391
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides stercoris co-metabolize the drug Ramelteon, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Venlafaxine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1679
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides stercoris co-metabolize the drug Venlafaxine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[35], [2] |
| Vilazodone hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1687
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides stercoris co-metabolize the drug Vilazodone hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[24], [2] |
| Bacteroides thetaiotaomicron (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 14 Drugs Metabolized
|
| Amoxicillin |
Click to Show/Hide the Detail |
| Drug ID |
DR0104
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides thetaiotaomicron co-metabolize the drug Amoxicillin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [27] |
| Carisoprodol |
Click to Show/Hide the Detail |
| Drug ID |
DR0277
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides thetaiotaomicron co-metabolize the drug Carisoprodol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[28], [2] |
| Clopidogrel bisulfate |
Click to Show/Hide the Detail |
| Drug ID |
DR0355
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides thetaiotaomicron co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[29], [2] |
| Diltiazem hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0509
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides thetaiotaomicron co-metabolize the drug Diltiazem hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[23], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides thetaiotaomicron co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Gliclazide |
Click to Show/Hide the Detail |
| Drug ID |
DR0776
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides thetaiotaomicron co-metabolize the drug Gliclazide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[33], [2] |
| Indomethacin |
Click to Show/Hide the Detail |
| Drug ID |
DR0875
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides thetaiotaomicron co-metabolize the drug Indomethacin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides thetaiotaomicron co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [8] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides thetaiotaomicron co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides thetaiotaomicron co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides thetaiotaomicron co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Ramelteon |
Click to Show/Hide the Detail |
| Drug ID |
DR1391
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides thetaiotaomicron co-metabolize the drug Ramelteon, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Vilazodone hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1687
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides thetaiotaomicron co-metabolize the drug Vilazodone hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[24], [2] |
| Voriconazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1709
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides thetaiotaomicron co-metabolize the drug Voriconazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[36], [2] |
| Bacteroides uniformis (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 7 Drugs Metabolized
|
| Amoxicillin |
Click to Show/Hide the Detail |
| Drug ID |
DR0104
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides uniformis co-metabolize the drug Amoxicillin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [27] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides uniformis co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides uniformis co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides uniformis co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides uniformis co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides uniformis co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Vilazodone hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1687
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides uniformis co-metabolize the drug Vilazodone hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[24], [2] |
| Bacteroides vulgatus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 18 Drugs Metabolized
|
| Amoxicillin |
Click to Show/Hide the Detail |
| Drug ID |
DR0104
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides vulgatus co-metabolize the drug Amoxicillin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [27], [42] |
| Carisoprodol |
Click to Show/Hide the Detail |
| Drug ID |
DR0277
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides vulgatus co-metabolize the drug Carisoprodol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[28], [2] |
| Clopidogrel bisulfate |
Click to Show/Hide the Detail |
| Drug ID |
DR0355
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides vulgatus co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[29], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides vulgatus co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Gliclazide |
Click to Show/Hide the Detail |
| Drug ID |
DR0776
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides vulgatus co-metabolize the drug Gliclazide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[33], [2] |
| Indomethacin |
Click to Show/Hide the Detail |
| Drug ID |
DR0875
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) metabolizes the drug Indomethacin, and Bacteroides vulgatus further metabolizes its metabolite (Indomethacin glucuronide), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[4], [43] |
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides vulgatus co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides vulgatus co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides vulgatus co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides vulgatus co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Phenytoin |
Click to Show/Hide the Detail |
| Drug ID |
DR1282
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides vulgatus co-metabolize the drug Phenytoin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
| Ramelteon |
Click to Show/Hide the Detail |
| Drug ID |
DR1391
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides vulgatus co-metabolize the drug Ramelteon, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides vulgatus co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Venlafaxine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1679
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides vulgatus co-metabolize the drug Venlafaxine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[35], [2] |
| Verapamil hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1681
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides vulgatus co-metabolize the drug Verapamil hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[44], [2] |
| Vilazodone hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1687
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides vulgatus co-metabolize the drug Vilazodone hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[24], [2] |
| Voriconazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1709
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides vulgatus co-metabolize the drug Voriconazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[36], [2] |
| Warfarin sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1717
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides vulgatus co-metabolize the drug Warfarin sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[40], [2] |
| Bacteroides xylanisolvens (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 13 Drugs Metabolized
|
| Carisoprodol |
Click to Show/Hide the Detail |
| Drug ID |
DR0277
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides xylanisolvens co-metabolize the drug Carisoprodol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[28], [2] |
| Clopidogrel bisulfate |
Click to Show/Hide the Detail |
| Drug ID |
DR0355
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides xylanisolvens co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[29], [2] |
| Diltiazem hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0509
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides xylanisolvens co-metabolize the drug Diltiazem hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[23], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides xylanisolvens co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Indomethacin |
Click to Show/Hide the Detail |
| Drug ID |
DR0875
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides xylanisolvens co-metabolize the drug Indomethacin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides xylanisolvens co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides xylanisolvens co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides xylanisolvens co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides xylanisolvens co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Phenytoin |
Click to Show/Hide the Detail |
| Drug ID |
DR1282
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides xylanisolvens co-metabolize the drug Phenytoin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
| Ramelteon |
Click to Show/Hide the Detail |
| Drug ID |
DR1391
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides xylanisolvens co-metabolize the drug Ramelteon, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Vilazodone hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1687
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides xylanisolvens co-metabolize the drug Vilazodone hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[24], [2] |
| Voriconazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1709
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides xylanisolvens co-metabolize the drug Voriconazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[36], [2] |
| Capnocytophaga gingivalis (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Amoxicillin |
Click to Show/Hide the Detail |
| Drug ID |
DR0104
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Capnocytophaga gingivalis co-metabolize the drug Amoxicillin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [45] |
| Capnocytophaga granulosa (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Amoxicillin |
Click to Show/Hide the Detail |
| Drug ID |
DR0104
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Capnocytophaga granulosa co-metabolize the drug Amoxicillin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [45] |
| Capnocytophaga haemolytica (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Amoxicillin |
Click to Show/Hide the Detail |
| Drug ID |
DR0104
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Capnocytophaga haemolytica co-metabolize the drug Amoxicillin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [46] |
| Capnocytophaga leadbetteri (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Amoxicillin |
Click to Show/Hide the Detail |
| Drug ID |
DR0104
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Capnocytophaga leadbetteri co-metabolize the drug Amoxicillin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [45] |
| Capnocytophaga ochracea (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Amoxicillin |
Click to Show/Hide the Detail |
| Drug ID |
DR0104
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Capnocytophaga ochracea co-metabolize the drug Amoxicillin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [45] |
| Capnocytophaga sputigena (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Amoxicillin |
Click to Show/Hide the Detail |
| Drug ID |
DR0104
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Capnocytophaga sputigena co-metabolize the drug Amoxicillin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [45] |
| Odoribacter splanchnicus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 14 Drugs Metabolized
|
| Amoxicillin |
Click to Show/Hide the Detail |
| Drug ID |
DR0104
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Odoribacter splanchnicus co-metabolize the drug Amoxicillin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [47], [48] |
| Clopidogrel bisulfate |
Click to Show/Hide the Detail |
| Drug ID |
DR0355
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Odoribacter splanchnicus co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[29], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Odoribacter splanchnicus co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Gliclazide |
Click to Show/Hide the Detail |
| Drug ID |
DR0776
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Odoribacter splanchnicus co-metabolize the drug Gliclazide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[33], [2] |
| Glipizide |
Click to Show/Hide the Detail |
| Drug ID |
DR0778
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Odoribacter splanchnicus co-metabolize the drug Glipizide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[30], [2] |
| Indomethacin |
Click to Show/Hide the Detail |
| Drug ID |
DR0875
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Odoribacter splanchnicus co-metabolize the drug Indomethacin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Odoribacter splanchnicus co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Odoribacter splanchnicus co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Odoribacter splanchnicus co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Odoribacter splanchnicus co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Ramelteon |
Click to Show/Hide the Detail |
| Drug ID |
DR1391
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Odoribacter splanchnicus co-metabolize the drug Ramelteon, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Odoribacter splanchnicus co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Vilazodone hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1687
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Odoribacter splanchnicus co-metabolize the drug Vilazodone hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[24], [2] |
| Voriconazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1709
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Odoribacter splanchnicus co-metabolize the drug Voriconazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[36], [2] |
| Parabacteroides distasonis (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 12 Drugs Metabolized
|
| Amoxicillin |
Click to Show/Hide the Detail |
| Drug ID |
DR0104
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Parabacteroides distasonis co-metabolize the drug Amoxicillin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [49] |
| Carisoprodol |
Click to Show/Hide the Detail |
| Drug ID |
DR0277
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Parabacteroides distasonis co-metabolize the drug Carisoprodol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[28], [2] |
| Clopidogrel bisulfate |
Click to Show/Hide the Detail |
| Drug ID |
DR0355
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Parabacteroides distasonis co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[29], [2] |
| Diltiazem hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0509
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Parabacteroides distasonis co-metabolize the drug Diltiazem hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[23], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Parabacteroides distasonis co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Gliclazide |
Click to Show/Hide the Detail |
| Drug ID |
DR0776
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Parabacteroides distasonis co-metabolize the drug Gliclazide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[33], [2] |
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Parabacteroides distasonis co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Parabacteroides distasonis co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Phenytoin |
Click to Show/Hide the Detail |
| Drug ID |
DR1282
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Parabacteroides distasonis co-metabolize the drug Phenytoin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
| Ramelteon |
Click to Show/Hide the Detail |
| Drug ID |
DR1391
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Parabacteroides distasonis co-metabolize the drug Ramelteon, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Vilazodone hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1687
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Parabacteroides distasonis co-metabolize the drug Vilazodone hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[24], [2] |
| Voriconazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1709
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Parabacteroides distasonis co-metabolize the drug Voriconazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[36], [2] |
| Parabacteroides johnsonii (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 10 Drugs Metabolized
|
| Clopidogrel bisulfate |
Click to Show/Hide the Detail |
| Drug ID |
DR0355
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Parabacteroides johnsonii co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[29], [2] |
| Diltiazem hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0509
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Parabacteroides johnsonii co-metabolize the drug Diltiazem hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[23], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Parabacteroides johnsonii co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Parabacteroides johnsonii co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Parabacteroides johnsonii co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Parabacteroides johnsonii co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Parabacteroides johnsonii co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Ranitidine |
Click to Show/Hide the Detail |
| Drug ID |
DR1393
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Parabacteroides johnsonii co-metabolize the drug Ranitidine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[6], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Parabacteroides johnsonii co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Vilazodone hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1687
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Parabacteroides johnsonii co-metabolize the drug Vilazodone hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[24], [2] |
| Parabacteroides merdae (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 9 Drugs Metabolized
|
| Clopidogrel bisulfate |
Click to Show/Hide the Detail |
| Drug ID |
DR0355
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Parabacteroides merdae co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[29], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Parabacteroides merdae co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Indomethacin |
Click to Show/Hide the Detail |
| Drug ID |
DR0875
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Parabacteroides merdae co-metabolize the drug Indomethacin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Parabacteroides merdae co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Parabacteroides merdae co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Parabacteroides merdae co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Parabacteroides merdae co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Ramelteon |
Click to Show/Hide the Detail |
| Drug ID |
DR1391
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Parabacteroides merdae co-metabolize the drug Ramelteon, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Vilazodone hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1687
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Parabacteroides merdae co-metabolize the drug Vilazodone hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[24], [2] |
| Prevotella bivia (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Amoxicillin |
Click to Show/Hide the Detail |
| Drug ID |
DR0104
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Prevotella bivia co-metabolize the drug Amoxicillin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [47], [48] |
| Prevotella buccae (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Amoxicillin |
Click to Show/Hide the Detail |
| Drug ID |
DR0104
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Prevotella buccae co-metabolize the drug Amoxicillin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [46] |
| Prevotella copri (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 11 Drugs Metabolized
|
| Amoxicillin |
Click to Show/Hide the Detail |
| Drug ID |
DR0104
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Prevotella copri co-metabolize the drug Amoxicillin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [50] |
| Aspirin |
Click to Show/Hide the Detail |
| Drug ID |
DR1749
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Prevotella copri co-metabolize the drug Aspirin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[51], [52] |
| Carisoprodol |
Click to Show/Hide the Detail |
| Drug ID |
DR0277
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Prevotella copri co-metabolize the drug Carisoprodol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[28], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Prevotella copri co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Prevotella copri co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Prevotella copri co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Prevotella copri co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Prevotella copri co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Ramelteon |
Click to Show/Hide the Detail |
| Drug ID |
DR1391
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Prevotella copri co-metabolize the drug Ramelteon, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Prevotella copri co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Vilazodone hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1687
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Prevotella copri co-metabolize the drug Vilazodone hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[24], [2] |
| Prevotella denticola (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Amoxicillin |
Click to Show/Hide the Detail |
| Drug ID |
DR0104
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Prevotella denticola co-metabolize the drug Amoxicillin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [46] |
| Prevotella intermedia (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Amoxicillin |
Click to Show/Hide the Detail |
| Drug ID |
DR0104
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Prevotella intermedia co-metabolize the drug Amoxicillin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [26] |
| Prevotella loescheii (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Amoxicillin |
Click to Show/Hide the Detail |
| Drug ID |
DR0104
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Prevotella loescheii co-metabolize the drug Amoxicillin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [46] |
| Prevotella melaninogenica (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Amoxicillin |
Click to Show/Hide the Detail |
| Drug ID |
DR0104
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Prevotella melaninogenica co-metabolize the drug Amoxicillin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [46], [53] |
| Prevotella nigrescens (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Amoxicillin |
Click to Show/Hide the Detail |
| Drug ID |
DR0104
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Prevotella nigrescens co-metabolize the drug Amoxicillin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [26], [46] |
| Prevotella oralis (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Amoxicillin |
Click to Show/Hide the Detail |
| Drug ID |
DR0104
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Prevotella oralis co-metabolize the drug Amoxicillin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [47], [48] |
| Prevotella veroralis (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Amoxicillin |
Click to Show/Hide the Detail |
| Drug ID |
DR0104
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Prevotella veroralis co-metabolize the drug Amoxicillin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [46] |
| Bacteria: Firmicutes |
| Acidaminococcus fermentans (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Amoxicillin |
Click to Show/Hide the Detail |
| Drug ID |
DR0104
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Acidaminococcus fermentans co-metabolize the drug Amoxicillin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [54] |
| Acidaminococcus intestini (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Amoxicillin |
Click to Show/Hide the Detail |
| Drug ID |
DR0104
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Acidaminococcus intestini co-metabolize the drug Amoxicillin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [55] |
| Anaerobutyricum hallii (firmicutes) |
Click to Show/Hide the Full List of Drugs: 4 Drugs Metabolized
|
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Anaerobutyricum hallii co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Anaerobutyricum hallii co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Anaerobutyricum hallii co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Anaerobutyricum hallii co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Anaerococcus hydrogenalis (firmicutes) |
Click to Show/Hide the Full List of Drugs: 4 Drugs Metabolized
|
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Anaerococcus hydrogenalis co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Anaerococcus hydrogenalis co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Anaerococcus hydrogenalis co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Zidovudine |
Click to Show/Hide the Detail |
| Drug ID |
DR1729
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Anaerococcus hydrogenalis co-metabolize the drug Zidovudine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [2] |
| Anaerostipes hadrus (firmicutes) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Anaerostipes hadrus co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Anaerostipes hadrus co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Anaerotruncus colihominis (firmicutes) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Anaerotruncus colihominis co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Anaerotruncus colihominis co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Anaerotruncus colihominis co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Bacillus megaterium (firmicutes) |
Click to Show/Hide the Full List of Drugs: 5 Drugs Metabolized
|
| Dextromethorphan hydrobromide |
Click to Show/Hide the Detail |
| Drug ID |
DR0476
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacillus megaterium co-metabolize the drug Dextromethorphan hydrobromide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[13], [56] |
| Diclofenac sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR0488
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacillus megaterium co-metabolize the drug Diclofenac sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[17], [57] |
| Progesterone |
Click to Show/Hide the Detail |
| Drug ID |
DR1346
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacillus megaterium co-metabolize the drug Progesterone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[20], [58] |
| Propranolol hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1367
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacillus megaterium co-metabolize the drug Propranolol hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[59], [58] |
| Testosterone cypionate |
Click to Show/Hide the Detail |
| Drug ID |
DR1564
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacillus megaterium co-metabolize the drug Testosterone cypionate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[20], [58], [60] |
| Bacillus pumilus (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Chloramphenicol |
Click to Show/Hide the Detail |
| Drug ID |
DR0298
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacillus pumilus co-metabolize the drug Chloramphenicol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[61], [62] |
| Bacteroides pectinophilus (firmicutes) |
Click to Show/Hide the Full List of Drugs: 5 Drugs Metabolized
|
| Carisoprodol |
Click to Show/Hide the Detail |
| Drug ID |
DR0277
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides pectinophilus co-metabolize the drug Carisoprodol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[28], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides pectinophilus co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides pectinophilus co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides pectinophilus co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Bacteroides pectinophilus co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Blautia hansenii (firmicutes) |
Click to Show/Hide the Full List of Drugs: 12 Drugs Metabolized
|
| Carisoprodol |
Click to Show/Hide the Detail |
| Drug ID |
DR0277
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Blautia hansenii co-metabolize the drug Carisoprodol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[28], [2] |
| Clopidogrel bisulfate |
Click to Show/Hide the Detail |
| Drug ID |
DR0355
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Blautia hansenii co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[29], [2] |
| Cyclophosphamide |
Click to Show/Hide the Detail |
| Drug ID |
DR0391
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Blautia hansenii co-metabolize the drug Cyclophosphamide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[22], [2] |
| Diltiazem hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0509
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Blautia hansenii co-metabolize the drug Diltiazem hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[23], [2] |
| Doxazosin |
Click to Show/Hide the Detail |
| Drug ID |
DR0542
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Blautia hansenii co-metabolize the drug Doxazosin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[32], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Blautia hansenii co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Blautia hansenii co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Blautia hansenii co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Blautia hansenii co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Ramelteon |
Click to Show/Hide the Detail |
| Drug ID |
DR1391
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Blautia hansenii co-metabolize the drug Ramelteon, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
| Sildenafil citrate |
Click to Show/Hide the Detail |
| Drug ID |
DR1481
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Blautia hansenii co-metabolize the drug Sildenafil citrate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[63], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Blautia hansenii co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Blautia luti (firmicutes) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Blautia luti co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Blautia luti co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Clostridioides difficile (firmicutes) |
Click to Show/Hide the Full List of Drugs: 4 Drugs Metabolized
|
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Clostridioides difficile co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Clostridioides difficile co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Clostridioides difficile co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Sildenafil citrate |
Click to Show/Hide the Detail |
| Drug ID |
DR1481
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Clostridioides difficile co-metabolize the drug Sildenafil citrate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[63], [2] |
| Clostridium botulinum (firmicutes) |
Click to Show/Hide the Full List of Drugs: 13 Drugs Metabolized
|
| Carisoprodol |
Click to Show/Hide the Detail |
| Drug ID |
DR0277
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Clostridium botulinum co-metabolize the drug Carisoprodol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[28], [2] |
| Clopidogrel bisulfate |
Click to Show/Hide the Detail |
| Drug ID |
DR0355
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Clostridium botulinum co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[29], [2] |
| Diltiazem hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0509
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Clostridium botulinum co-metabolize the drug Diltiazem hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[23], [2] |
| Doxazosin |
Click to Show/Hide the Detail |
| Drug ID |
DR0542
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Clostridium botulinum co-metabolize the drug Doxazosin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[32], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Clostridium botulinum co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Clostridium botulinum co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Methsuximide |
Click to Show/Hide the Detail |
| Drug ID |
DR1050
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Clostridium botulinum co-metabolize the drug Methsuximide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[34], [2] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Clostridium botulinum co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Clostridium botulinum co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Clostridium botulinum co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Paroxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1245
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Clostridium botulinum co-metabolize the drug Paroxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[64], [2] |
| Sildenafil citrate |
Click to Show/Hide the Detail |
| Drug ID |
DR1481
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Clostridium botulinum co-metabolize the drug Sildenafil citrate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[63], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Clostridium botulinum co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Clostridium perfringens (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Clostridium perfringens co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [8] |
| Clostridium scindens (firmicutes) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Clostridium scindens co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Clostridium scindens co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Clostridium scindens co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Clostridium spiroforme (firmicutes) |
Click to Show/Hide the Full List of Drugs: 4 Drugs Metabolized
|
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Clostridium spiroforme co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Clostridium spiroforme co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Clostridium spiroforme co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Vilazodone hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1687
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Clostridium spiroforme co-metabolize the drug Vilazodone hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[24], [2] |
| Clostridium sporogenes (firmicutes) |
Click to Show/Hide the Full List of Drugs: 6 Drugs Metabolized
|
| Clopidogrel bisulfate |
Click to Show/Hide the Detail |
| Drug ID |
DR0355
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Clostridium sporogenes co-metabolize the drug Clopidogrel bisulfate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[29], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Clostridium sporogenes co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Clostridium sporogenes co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Clostridium sporogenes co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Vilazodone hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1687
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Clostridium sporogenes co-metabolize the drug Vilazodone hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[24], [2] |
| Zonisamide |
Click to Show/Hide the Detail |
| Drug ID |
DR1737
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Clostridium sporogenes co-metabolize the drug Zonisamide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[65], [66] |
| Clostridium symbiosum (firmicutes) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Clostridium symbiosum co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Clostridium symbiosum co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Clostridium symbiosum co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Coprococcus comes (firmicutes) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Coprococcus comes co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Coprococcus comes co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Coprococcus comes co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Dorea formicigenerans (firmicutes) |
Click to Show/Hide the Full List of Drugs: 4 Drugs Metabolized
|
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Dorea formicigenerans co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Dorea formicigenerans co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Dorea formicigenerans co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Dorea formicigenerans co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Enterocloster asparagiformis (firmicutes) |
Click to Show/Hide the Full List of Drugs: 4 Drugs Metabolized
|
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Enterocloster asparagiformis co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Enterocloster asparagiformis co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Enterocloster asparagiformis co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Enterocloster asparagiformis co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Enterocloster bolteae (firmicutes) |
Click to Show/Hide the Full List of Drugs: 4 Drugs Metabolized
|
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Enterocloster bolteae co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Enterocloster bolteae co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Enterocloster bolteae co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Enterocloster bolteae co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Enterococcus faecalis (firmicutes) |
Click to Show/Hide the Full List of Drugs: 4 Drugs Metabolized
|
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Enterococcus faecalis co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Enterococcus faecalis co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Enterococcus faecalis co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Ranitidine |
Click to Show/Hide the Detail |
| Drug ID |
DR1393
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Enterococcus faecalis co-metabolize the drug Ranitidine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[6], [2] |
| Erysipelatoclostridium ramosum (firmicutes) |
Click to Show/Hide the Full List of Drugs: 4 Drugs Metabolized
|
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Erysipelatoclostridium ramosum co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Indomethacin |
Click to Show/Hide the Detail |
| Drug ID |
DR0875
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) metabolizes the drug Indomethacin, and Erysipelatoclostridium ramosum further metabolizes its metabolite (Indomethacin glucuronide), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[4], [43] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Erysipelatoclostridium ramosum co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Erysipelatoclostridium ramosum co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Erysipelothrix rhusiopathiae (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Chloramphenicol |
Click to Show/Hide the Detail |
| Drug ID |
DR0298
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Erysipelothrix rhusiopathiae co-metabolize the drug Chloramphenicol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[61], [67], [68] |
| Eubacterium limosum (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Eubacterium limosum co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [8] |
| Eubacterium rectale (firmicutes) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Eubacterium rectale co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Eubacterium rectale co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Eubacterium rectale co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Eubacterium ventriosum (firmicutes) |
Click to Show/Hide the Full List of Drugs: 4 Drugs Metabolized
|
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Eubacterium ventriosum co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Eubacterium ventriosum co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Eubacterium ventriosum co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Eubacterium ventriosum co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Faecalibacterium prausnitzii (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Diclofenac sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR0488
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) metabolizes the drug Diclofenac sodium, and Faecalibacterium prausnitzii further metabolizes its metabolite (Diclofenac glucuronide), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[17], [31] |
| Holdemanella biformis (firmicutes) |
Click to Show/Hide the Full List of Drugs: 7 Drugs Metabolized
|
| Cyclophosphamide |
Click to Show/Hide the Detail |
| Drug ID |
DR0391
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Holdemanella biformis co-metabolize the drug Cyclophosphamide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[22], [2] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Holdemanella biformis co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Glipizide |
Click to Show/Hide the Detail |
| Drug ID |
DR0778
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Holdemanella biformis co-metabolize the drug Glipizide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[30], [2] |
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Holdemanella biformis co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Holdemanella biformis co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Holdemanella biformis co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Holdemanella biformis co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Hungatella hathewayi (firmicutes) |
Click to Show/Hide the Full List of Drugs: 5 Drugs Metabolized
|
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Hungatella hathewayi co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Hungatella hathewayi co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Hungatella hathewayi co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Ranitidine |
Click to Show/Hide the Detail |
| Drug ID |
DR1393
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Hungatella hathewayi co-metabolize the drug Ranitidine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[6], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Hungatella hathewayi co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Jeotgalicoccus psychrophilus (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Aspirin |
Click to Show/Hide the Detail |
| Drug ID |
DR1749
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Jeotgalicoccus psychrophilus co-metabolize the drug Aspirin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[51], [52] |
| Lactobacillus reuteri (firmicutes) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Lactobacillus reuteri co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Lactobacillus reuteri co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Lactobacillus reuteri co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Lactobacillus rhamnosus (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Diclofenac sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR0488
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) metabolizes the drug Diclofenac sodium, and Lactobacillus rhamnosus further metabolizes its metabolite (Diclofenac glucuronide), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[17], [31] |
| Marvinbryantia formatexigens (firmicutes) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Marvinbryantia formatexigens co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Marvinbryantia formatexigens co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Peptostreptococcus anaerobius (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Amoxicillin |
Click to Show/Hide the Detail |
| Drug ID |
DR0104
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Peptostreptococcus anaerobius co-metabolize the drug Amoxicillin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [46] |
| Pseudoflavonifractor capillosus (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Amoxicillin |
Click to Show/Hide the Detail |
| Drug ID |
DR0104
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Pseudoflavonifractor capillosus co-metabolize the drug Amoxicillin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [69] |
| Roseburia hominis (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Indomethacin |
Click to Show/Hide the Detail |
| Drug ID |
DR0875
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) metabolizes the drug Indomethacin, and Roseburia hominis further metabolizes its metabolite (Indomethacin glucuronide), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[4], [43] |
| Roseburia intestinalis (firmicutes) |
Click to Show/Hide the Full List of Drugs: 5 Drugs Metabolized
|
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Roseburia intestinalis co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Indomethacin |
Click to Show/Hide the Detail |
| Drug ID |
DR0875
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) metabolizes the drug Indomethacin, and Roseburia intestinalis further metabolizes its metabolite (Indomethacin glucuronide), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[4], [43] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Roseburia intestinalis co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Roseburia intestinalis co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Roseburia intestinalis co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Ruminococcus albus (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Aspirin |
Click to Show/Hide the Detail |
| Drug ID |
DR1749
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Ruminococcus albus co-metabolize the drug Aspirin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[51], [52] |
| Ruminococcus gnavus (firmicutes) |
Click to Show/Hide the Full List of Drugs: 6 Drugs Metabolized
|
| Diclofenac sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR0488
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) metabolizes the drug Diclofenac sodium, and Ruminococcus gnavus further metabolizes its metabolite (Diclofenac glucuronide), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[17], [31] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Ruminococcus gnavus co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Ruminococcus gnavus co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Ruminococcus gnavus co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Ruminococcus gnavus co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Ruminococcus gnavus co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Ruminococcus lactaris (firmicutes) |
Click to Show/Hide the Full List of Drugs: 4 Drugs Metabolized
|
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Ruminococcus lactaris co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Ruminococcus lactaris co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Ruminococcus lactaris co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Ruminococcus lactaris co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Ruminococcus torques (firmicutes) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Ruminococcus torques co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Ruminococcus torques co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Ruminococcus torques co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Subdoligranulum variabile (firmicutes) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Subdoligranulum variabile co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Subdoligranulum variabile co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Subdoligranulum variabile co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Bacteria: Fusobacteria |
| Fusobacterium mortiferum (fusobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Amoxicillin |
Click to Show/Hide the Detail |
| Drug ID |
DR0104
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Fusobacterium mortiferum co-metabolize the drug Amoxicillin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [47], [48] |
| Fusobacterium varium (fusobacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Amoxicillin |
Click to Show/Hide the Detail |
| Drug ID |
DR0104
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Fusobacterium varium co-metabolize the drug Amoxicillin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [47] |
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Fusobacterium varium co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [8] |
| Bacteria: Lentisphaerae |
| Victivallis vadensis (PVC bacteria) |
Click to Show/Hide the Full List of Drugs: 4 Drugs Metabolized
|
| Diltiazem hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0509
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Victivallis vadensis co-metabolize the drug Diltiazem hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[23], [2] |
| Lovastatin |
Click to Show/Hide the Detail |
| Drug ID |
DR0986
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Victivallis vadensis co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Victivallis vadensis co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Victivallis vadensis co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Bacteria: Proteobacteria |
| Achromobacter xylosoxidans (beta-proteobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Amoxicillin |
Click to Show/Hide the Detail |
| Drug ID |
DR0104
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Achromobacter xylosoxidans co-metabolize the drug Amoxicillin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [70] |
| Acidovorax ebreus (beta-proteobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Amoxicillin |
Click to Show/Hide the Detail |
| Drug ID |
DR0104
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Acidovorax ebreus co-metabolize the drug Amoxicillin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [71] |
| Citrobacter freundii (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Amoxicillin |
Click to Show/Hide the Detail |
| Drug ID |
DR0104
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Citrobacter freundii co-metabolize the drug Amoxicillin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [46] |
| Edwardsiella tarda (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Edwardsiella tarda co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Edwardsiella tarda co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Edwardsiella tarda co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Enterobacter cancerogenus (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 4 Drugs Metabolized
|
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Enterobacter cancerogenus co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Enterobacter cancerogenus co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Enterobacter cancerogenus co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Enterobacter cancerogenus co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Escherichia coli (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 7 Drugs Metabolized
|
| Chloramphenicol |
Click to Show/Hide the Detail |
| Drug ID |
DR0298
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Escherichia coli co-metabolize the drug Chloramphenicol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[61], [62] |
| Flunitrazepam |
Click to Show/Hide the Detail |
| Drug ID |
DR0712
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Escherichia coli co-metabolize the drug Flunitrazepam, which can collectively affect efficacy, safety or bioavailability of this drug. |
[72], [73] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Escherichia coli co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Indomethacin |
Click to Show/Hide the Detail |
| Drug ID |
DR0875
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) metabolizes the drug Indomethacin, and Escherichia coli further metabolizes its metabolite (Indomethacin glucuronide), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[4], [74] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Escherichia coli co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Escherichia coli co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Escherichia coli co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Helicobacter apodemus (epsilon-proteobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Aspirin |
Click to Show/Hide the Detail |
| Drug ID |
DR1749
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Helicobacter apodemus co-metabolize the drug Aspirin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[51], [52] |
| Klebsiella aerogenes (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Amoxicillin |
Click to Show/Hide the Detail |
| Drug ID |
DR0104
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Klebsiella aerogenes co-metabolize the drug Amoxicillin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [70] |
| Klebsiella pneumoniae (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Amoxicillin |
Click to Show/Hide the Detail |
| Drug ID |
DR0104
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Klebsiella pneumoniae co-metabolize the drug Amoxicillin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [70] |
| Neisseria sicca (beta-proteobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Amoxicillin |
Click to Show/Hide the Detail |
| Drug ID |
DR0104
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Neisseria sicca co-metabolize the drug Amoxicillin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [46] |
| Photorhabdus asymbiotica (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Amoxicillin |
Click to Show/Hide the Detail |
| Drug ID |
DR0104
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Photorhabdus asymbiotica co-metabolize the drug Amoxicillin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [75], [76] |
| Proteus penneri (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 5 Drugs Metabolized
|
| Chloramphenicol |
Click to Show/Hide the Detail |
| Drug ID |
DR0298
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Proteus penneri co-metabolize the drug Chloramphenicol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[61], [62] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Proteus penneri co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Proteus penneri co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Proteus penneri co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Proteus penneri co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Providencia alcalifaciens (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Providencia alcalifaciens co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Providencia alcalifaciens co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Providencia rettgeri (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Providencia rettgeri co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Providencia rettgeri co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Providencia stuartii (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 4 Drugs Metabolized
|
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Providencia stuartii co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Providencia stuartii co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Providencia stuartii co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Terbinafine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1557
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Providencia stuartii co-metabolize the drug Terbinafine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [2] |
| Pseudomonas putida (gamma-proteobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Nicotine |
Click to Show/Hide the Detail |
| Drug ID |
DR1148
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Pseudomonas putida co-metabolize the drug Nicotine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[77], [78] |
| Salmonella enterica (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 4 Drugs Metabolized
|
| Amoxicillin |
Click to Show/Hide the Detail |
| Drug ID |
DR0104
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Salmonella enterica co-metabolize the drug Amoxicillin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [79] |
| Fluoxetine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0720
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Salmonella enterica co-metabolize the drug Fluoxetine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Salmonella enterica co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Salmonella enterica co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Shigella sonnei (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Amoxicillin |
Click to Show/Hide the Detail |
| Drug ID |
DR0104
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Shigella sonnei co-metabolize the drug Amoxicillin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[25], [80] |
| Sphingomonas colocasiae (alpha-proteobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Ibuprofen |
Click to Show/Hide the Detail |
| Drug ID |
DR0844
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Sphingomonas colocasiae co-metabolize the drug Ibuprofen, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [81] |
| Bacteria: Verrucomicrobia |
| Akkermansia muciniphila (verrucomicrobiae) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| Naftopidil |
Click to Show/Hide the Detail |
| Drug ID |
DR1124
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Akkermansia muciniphila co-metabolize the drug Naftopidil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[39], [2] |
| Omeprazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1196
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Akkermansia muciniphila co-metabolize the drug Omeprazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
| Pantoprazole sodium |
Click to Show/Hide the Detail |
| Drug ID |
DR1236
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Akkermansia muciniphila co-metabolize the drug Pantoprazole sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Archaea: Euryarchaeota |
| Methanobrevibacter oralis (methanobacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Chloramphenicol |
Click to Show/Hide the Detail |
| Drug ID |
DR0298
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Methanobrevibacter oralis co-metabolize the drug Chloramphenicol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[61], [82] |
| Rifampicin |
Click to Show/Hide the Detail |
| Drug ID |
DR1420
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Methanobrevibacter oralis co-metabolize the drug Rifampicin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[15], [82] |
| Methanobrevibacter smithii (methanobacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Chloramphenicol |
Click to Show/Hide the Detail |
| Drug ID |
DR0298
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Methanobrevibacter smithii co-metabolize the drug Chloramphenicol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[61], [82] |
| Rifampicin |
Click to Show/Hide the Detail |
| Drug ID |
DR1420
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Methanobrevibacter smithii co-metabolize the drug Rifampicin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[15], [82] |
| Methanomassiliicoccus luminyensis (thermoplasmata) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Chloramphenicol |
Click to Show/Hide the Detail |
| Drug ID |
DR0298
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Methanomassiliicoccus luminyensis co-metabolize the drug Chloramphenicol, which can collectively affect efficacy, safety or bioavailability of this drug. |
[61], [82] |
| Rifampicin |
Click to Show/Hide the Detail |
| Drug ID |
DR1420
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Methanomassiliicoccus luminyensis co-metabolize the drug Rifampicin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[15], [82] |
| Methanosphaera stadtmanae (methanobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Rifampicin |
Click to Show/Hide the Detail |
| Drug ID |
DR1420
Drug Info
|
| Interaction Mechanism |
Human Mephenytoin 4-hydroxylase (CYP2C19) and Methanosphaera stadtmanae co-metabolize the drug Rifampicin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[15], [82] |
|
|
|
|
|
|